Evaluation of calculating carboplatin dosage in carboplatin–pemetrexed therapy as the first‐line therapy for Chinese patients with advanced lung adenocarcinoma

OBJECTIVE: This study aims to explore the application of actual carboplatin in carboplatin plus pemetrexed regimen as first‐line treatment for advanced lung adenocarcinoma, and to determine the recommended dose of carboplatin for Chinese populations. METHODS: From January 2014 to April 2016, 151 adv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Zhu, Yixiang, Xing, Puyuan, Wang, Shouzheng, Ma, Di, Mu, Yuxin, Li, Xue, Xu, Ziyi, Li, Junling
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5832477/
https://ncbi.nlm.nih.gov/pubmed/29377581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12594
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky